NEW YORK, Nov. 16, 2021 (GLOBE NEWSWIRE) — via InvestorWire — IBN (InvestorBrandNetwork), a multifaceted communications organization engaged in connecting public companies to the investment community, is pleased to announce the release of the latest episode of The Bell2Bell Podcast as part of its sustained effort to provide specialized content distribution via widespread syndication channels.
The Bell2Bell Podcast delivers informative updates and exclusive interviews with executives operating in fast-moving industries. Bell2Bell’s latest podcast features Matt Stang, CEO of Delic Holdings Corp. (CSE: DELC) (OTCQB: DELCF), the leading psychedelic wellness platform committed to bringing science-backed benefits to all and reframing the psychedelic conversation.
Throughout the interview, Stang discussed the Delic ecosystem of businesses and examined how psychedelic research is driving a paradigm shift in the treatment of mental health.
“Delic is the world’s first psychedelic wellness corporation. We have three different businesses, but they all create this amazing ecosystem,” Stang said. “We have the largest chain of psychedelic wellness clinics in America, with 12 clinics operational today under the Ketamine Wellness Centers and Ketamine Infusion Centers brands. We have Delic Labs, a Health Canada-licensed lab in Vancouver with licenses to do scientific research around cannabis, hemp and psychedelics, doing work for major companies across the space. And we have a media and events platform. I just came back from the largest psychedelic event in America; it’s called Meet Delic. We had our first year; we had over 2,500 people in attendance and some incredible names speaking. Then, we have a media platform called Reality Sandwich, which gets a couple hundred thousand people a month looking for information about psychedelics.”
“We feel that the time is right now. The mental health crisis is sweeping not only this country but the world,” he continued. “Last year, in America, we had four-times the highest amount of suicides ever. People are dying. People are hurting, and there are no good methods in the current toolbox of medical technology. At Meet Delic, our giant psychedelic wellness event, one of the doctors that was on our panels said the thing that’s so exciting with psychedelics is that there are curative numbers – not treatment numbers.”
“Rather than treating a disease you are curing it. You look at where we’re at with ketamine right now, and the numbers are in the 70%, 80%, sometimes 90% range for actually making people well,” Stang added. “You have this amazing new paradigm shift in treating people’s mental health, and that’s what we’re at the forefront of, being the largest chain in America, being in 10 states within a fairly close drive to 25-30 million people right now. We think it’s just very important that people have access to this.”
Join IBN’s Stuart Smith and Matt Stang, CEO of Delic Holdings Corp. (CSE: DELC) (OTCQB: DELCF), to learn more about the company’s proven leadership team, recent milestones and operational goals for the balance of 2021 and beyond.
To hear the episode and subscribe for future podcasts, visit https://podcast.bell2bell.com.
The latest installment of The Bell2Bell Podcast continues to reinforce IBN’s commitment to the expansion of its robust network of brands, client partners, followers and the growing IBN Podcast Series. For more than 15 years, IBN has leveraged this commitment to provide unparalleled distribution and corporate messaging solutions to 500+ public and private companies.
To learn more about IBN’s achievements and milestones via a visual timeline, visit: https://IBN.fm/TimeLine
About Delic Corp.
Delic is a leader in new medicines and treatments for a modern world, improving access to health benefits across the country and reframing the conversation on psychedelics. The company owns and operates an umbrella of related businesses, including the largest chain of psychedelic wellness clinics in the country, including Ketamine Infusion Centers and Ketamine Wellness Centers; the only entity licensed by Health Canada to exclusively focus on research and development of psilocybin vaporization technology, Delic Labs; the premier psychedelic wellness event, Meet Delic; and trusted media and e-commerce platforms Reality Sandwich and Delic Radio. Delic is backed by a team of industry and cannabis veterans and a diverse network, whose mission is to provide education, research, high-quality products, and effective treatment options to the masses. For more information, visit the company’s website at www.DelicCorp.com.
IBN (InvestorBrandNetwork) consists of financial brands introduced to the investment public over the course of 15+ years. With IBN, we have amassed a collective audience of millions of social media followers. These distinctive investor brands aim to fulfill the unique needs of a growing base of client-partners. IBN will continue to expand our branded network of highly influential properties, leveraging the knowledge and energy of specialized teams of experts to serve our increasingly diversified list of clients.
Through NetworkNewsWire (“NNW”) and its affiliate brands, IBN provides: (1) access to a network of wire solutions via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible; (2) article and editorial syndication to 5,000+ news outlets; (3) enhanced press release solutions to ensure maximum impact; (4) full-scale distribution to a growing social media audience; (5) a full array of corporate communications solutions; and (6) a total news coverage solution.
For more information, please visit https://www.InvestorBrandNetwork.com.
This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. In evaluating such statements, prospective investors should review carefully various risks and uncertainties identified in this release and matters set in the company’s SEC filings. These risks and uncertainties could cause the company’s actual results to differ materially from those indicated in the forward-looking statements.